Underreported: Mefloquine use at Guantanamo
Thursday, January 06, 2011
Detainees held by the United States government at the Guantanamo Bay prison have been administered very high doses of the drug Mefloquine, according to a new report from Seton Hall Law School. While the drug is a powerful anti-malarial, it also has a number of adverse side effects, which include hallucinations, paranoia and depression. On today’s Underreported segment Mark Denbeaux, one of the reports authors and director of the Seton Hall Law Center for Policy & Research, discusses why administration of the drug to detainees (at five times the regular dosage) is controversial.